deltatrials
Recruiting PHASE1 INTERVENTIONAL 2-arm NCT05862012

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

A Phase 1, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 2001 in Subjects With Relapsed/Refractory Multiple Myeloma

Sponsor: Ichnos Sciences SA

Interventions ISB 2001
Updated 9 times since 2023 Last updated: Mar 11, 2026 Started: Nov 1, 2023 Primary completion: Jul 31, 2027 Completion: Jul 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Relapsed/Refractory Multiple Myeloma and is currently actively recruiting participants. Ichnos Sciences SA leads this study, which shows 9 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotRecruiting~Jan 2025 – ~Jul 2025 · 6 months · monthly snapshotRecruiting~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – ~Mar 2026 · 5 months · monthly snapshotRecruiting~Mar 2026 – present · 4 months · monthly snapshotRecruiting

Change History

9 versions recorded
  1. Mar 2026 — Present [monthly]

    Recruiting PHASE1

  2. Oct 2025 — Mar 2026 [monthly]

    Recruiting PHASE1

  3. Sep 2025 — Oct 2025 [monthly]

    Recruiting PHASE1

  4. Jul 2025 — Sep 2025 [monthly]

    Recruiting PHASE1

  5. Jan 2025 — Jul 2025 [monthly]

    Recruiting PHASE1

Show 4 earlier versions
  1. Sep 2024 — Jan 2025 [monthly]

    Recruiting PHASE1

  2. Aug 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  3. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE1

    Status: Not Yet RecruitingRecruiting

  4. Jun 2023 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ichnos Sciences SA
Data source: Ichnos Sciences SA

For direct contact, visit the study record on ClinicalTrials.gov .